A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the Proliferation, Immune response and RNA splicing modules in breast cancer-Reference-Cited by-同舟云学术

A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the Proliferation, Immune response and RNA splicing modules in breast cancer

Published:2008-11-13 Issue:6 Volume:10 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Reyal Fabien,van Vliet Martin H,Armstrong Nicola J,Horlings Hugo M,de Visser Karin E,Kok Marlen,Teschendorff Andrew E,Mook Stella,van 't Veer Laura,Caldas Carlos,Salmon Remy J,Vijver Marc J van de,Wessels Lodewyk FA

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/bcr2192.pdf

Reference59 articles.

1. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thürlimann B, Senn H-J: Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol. 2007, 18: 1133-1144.

2. Eifel P, Axelson JA, Costa J, Crowley J, Curran WJ, Deshler A, Fulton S, Hendricks CB, Kemeny M, Kornblith AB, Louis TA, Markman M, Mayer R, Roter D: National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1–3, 2000. J Natl Cancer Inst. 2001, 93: 979-989.

3. Blamey RW, Ellis IO, Pinder SE, Lee AHS, Macmillan RD, Morgan DAL, Robertson JFR, Mitchell MJ, Ball GR, Haybittle JL, Elston CW: Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990–1999. Eur J Cancer. 2007, 43: 1548-1555.

4. Ravdin PM, Siminoff LA, Davis GJ, Mercer MB, Hewlett J, Gerson N, Parker HL: Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol. 2001, 19: 980-991.

5. Early Breast Cancer Trialists' Collaborative Group: Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005, 365: 1687-1717.

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel survival prediction signature outperforms PAM50 and artificial intelligence-based feature-selection methods;Computational Biology and Chemistry;2023-06

2. Radiogenomic Analysis of Breast Cancer by Linking MRI Phenotypes with Tumor Gene Expression;Radiology;2020-08

3. MammaPrint and BluePrint Molecular Diagnostics Using Targeted RNA Next-Generation Sequencing Technology;The Journal of Molecular Diagnostics;2019-09

4. Genomic Applications in Breast Carcinoma;Genomic Applications in Pathology;2018-12-11

5. Pathway-structured predictive modeling for multi-level drug response in multiple myeloma;Bioinformatics;2018-05-29